Bipolaris Sorokiniana

Generic Name: bipolaris sorokiniana

Over-the-Counter (OTC)

Brand Names:

Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: COCHLIOBOLUS SATIVUS (40000 [PNU]/mL). Category: BLA.

Overview

Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: COCHLIOBOLUS SATIVUS (40000 [PNU]/mL). Category: BLA.

Dosage

Available as solution for intradermal, percutaneous, subcutaneous use.

Related Medications

Euphrasia Officinalis, Eye (suis), Aurum Metallicum, Calcarea Fluorica, Causticum, Conium Maculatum, Magnesia Carbonica, Phosphorus, Silicea, Physostigma Venenosum, Osmium Metallicum, Thuja Occidentalis

euphrasia officinalis, eye (suis), aurum metallicum, calcarea fluorica, causticum, conium maculatum, magnesia carbonica, phosphorus, silicea, physostigma venenosum, osmium metallicum, thuja occidentalis

Standardized Chemical Allergen [EPC]

INDICATIONS: May temporarily relieve minor inflammation and pressure in the eyes and burning and swelling of the eyelids.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Solid Dispersion Of Bms-986165-01

solid dispersion of bms-986165-01

Dosage form: POWDER. Active ingredients: DEUCRAVACITINIB (.15 kg/kg). Category: DRUG FOR FURTHER PROCESSING.

Theophylline Anhydrous

theophylline anhydrous

Methylxanthine [EPC]

DESCRIPTION Theophylline (Anhydrous) Extended-Release Tablets in a controlled-release system allows a 24-hour dosing interval for appropriate patients. Theophylline is structurally classified as a methylxanthine. It occurs as a white, odorless, crystalline powder with a bitter taste.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.